Stocks in the biotech space, that are making big moves in pre-market on Tuesday are (as of 8.20 am ET).
In the Green
Acurx Pharmaceuticals, Inc. (ACXP) is up over 235% at $1.03.Salarius Pharmaceuticals, Inc. (SLRX) is up over 95% at $1.23.Verve Therapeutics, Inc. (VERV)is up over 75% at $11.02.CERo Therapeutics Holdings, Inc. (CERO) is up over 56% at $10.78.ProPhase Labs, Inc. (PRPH) is up over 39% at $0.45.Prime Medicine, Inc. (PRME) is up over 20% at $1.80.ProPhase Labs, Inc. (PRPH) is up over 34% at $0.44.Moolec Science SA (MLEC) is up over 28% at $8.79.Azitra, Inc. (AZTR) is up over 26% at $0.34.Intellia Therapeutics, Inc. (NTLA) is up over 13% at $8.96.Citius Pharmaceuticals, Inc. (CTXR) is up over 11% at $0.88.Mineralys Therapeutics, Inc. (MLYS) is up over 10% at $14.90.scPharmaceuticals Inc. (SCPH) is up over 9% at $4.35.Eyenovia, Inc. (EYEN) is up over 9% at $3.45.Oscar Health, Inc. (OSCR) is up over 7% at $16.01.Lyell Immunopharma, Inc. (LYEL) is up over 7% at $10.94.China SXT Pharmaceuticals, Inc. (SXTC) is up over 6% at $1.85.Editas Medicine, Inc. (EDIT) is up over 6% at $2.31.Beam Therapeutics Inc. (BEAM) is up over 5% at $17.53.Arvinas, Inc. (ARVN) is up over 5% at $7.75.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.